2012

• Black, K., Haber, P., Lintzeris, N. (2012), Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction. , 1361-1362. [Abstract]
• Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012), Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review. 31(4), 499-506. [Abstract]
• Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012), Unplanned pregnancy and contraceptive use in women attending drug treatment services. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 52(2), 146-150. [Abstract]

2011

• Douglas, H., Boyle, M., Lintzeris, N. (2011), The health impacts of khat: a qualitative study among Somali-Australians. The Medical Journal of Australia. 195(11), 666-669. [Abstract]
• Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., Mattick, R., Ali, R., Horyniak, D. (2011), Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence. 118(2-3), 265-273. [Abstract]
• Longman, C., Lintzeris, N., Temple-Smith, M., Gilchrist, G. (2011), Methadone and buprenorphine prescribing patterns of Victorian general practitioners: Their first 5 years after authorisation. Drug and alcohol review. 30(4), 355-9. [Abstract]
• Mayet, S., Gossop, M., Lintzeris, N., Markides, V., Strang, J. (2011), Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation?. Drug and alcohol review. 30(4), 388-96. [Abstract]
• Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., Mattick, R. (2011), Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug and Alcohol Review. 30(3), 236-245. [Abstract]
• Nielsen, S., Bruno, R., Lintzeris, N., Fischer, J., Carruthers, S., Stoové, M. (2011), Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?. Drug and Alcohol Review. 30(3), 291-299. [Abstract]
• Winstock, A., Lintzeris, N., Lea, T. (2011), "Should I stay or should I go?" Coming off methadone and buprenorphine treatment. The International Journal on Drug Policy. 22(1), 77-81. [Abstract]

2010

• Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010), Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review. 29(5), 469-474. [Abstract]
• Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010), The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 105(2), 329-334. [Abstract]
• Lintzeris, N. (2010), Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers. Addiction. 105(2), 309-310. [Abstract]
• Forzisi, L., Mitchell, T., Bond, A., Lintzeris, N., Spofforth, N., Strang, J. (2010), Psychological performance and sedation following injectable opioid administration. Heroin Addiction and Related Clinical Problems. 12(3), 5-8.
• Lintzeris, N., Nielsen, S. (2010), Benzodiazepines, methadone and buprenorphine: interactions and clinical management. American Journal on Addictions. 19(1), 59-72. [Abstract]
• Miller, P., McKenzie, S., Lintzeris, N., Martina, A., Strang, J. (2010), The Community Impact of RIOTT, a Medically Supervised Injectable Maintenance Clinic in South London. Mental Health and Substance Use. 3(3), 248-259.

2009

• Winstock, A., Lintzeris, N., Lea, T. (2009), Why do patients report transferring between methadone and buprenorphine?. Drug and Alcohol Review. 28(6), 686-687. [Abstract]
• Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., Scheuer, N., Mattick, R. (2009), Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. The Medical Journal of Australia. 191(3), 161-165. [Abstract]
• Ridge, G., Gossop, M., Lintzeris, N., Witton, J., Strang, J. (2009), Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Journal of Substance Abuse Treatment. 37(1), 95-100. [Abstract]
• Bammer, G., Ritter, A., Kutin, J., Lintzeris, N. (2009), Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Australian and New Zealand Journal of Public Health. 33(1), 34-39. [Abstract]
• Lintzeris, N. (2009), Prescription of heroin for the management of heroin dependence: current status. CNS Drugs. 23(6), 463-476. [Abstract]
• Haber, P., Lintzeris, N., Proude, E., Lopatko, O. (2009), Guidelines for the Treatment of Alcohol Problems. Australia: Commonwealth of Australia.
• Morley, K., Haber, P., Lintzeris, N. (2009), Pharmacotherapies for alcohol dependence. In: Guidelines for the Treatment of Alcohol Problems. (pp.93-106).Australia: Commonwealth of Australia.
• Miller, P., Forzisi, L., Zador, D., Lintzeris, N., Metrebian, N., Van Der Waal, R., Mayet, S., Strang, J. (2009), Groin injecting in injectable opioid treatment service users in South London. Addiction Research & Theory. 17(4), 381-389. [Abstract]

2008

• Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008), Unplanned admissions to two Sydney public hospitals after naltrexone implants. The Medical Journal of Australia. 188(8), 441-444. [Abstract]
• Zador, D., Lintzeris, N., van der Waal, R., Miller, P., Metrebian, N., Strang, J. (2008), The fine line between harm reduction and harm production - development of a clinical policy on femoral (groin) Injecting. European addiction research. 14(4), 213-218. [Abstract]